Tucci, J.R., Tonino, R.P., Emkey, R.D., Peverly, C.A., Kher, U., Ii, A.C.S., et al. (1996) Effect of Three Years of Oral Alendronate Treatment Postmenopausal in Women with Osteoporosis. The American Journal of Medicine, 101, 488-501.
https://doi.org/10.1016/S0002-9343(96)00282-3

has been cited by the following article:

• TITLE: Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis

  AUTHORS: IsraaIsraa Ahmed Radwan, Nahed Sedky Korany, Bassant Adel Ezzat

  KEYWORDS: Bisphosphonates, Alendronate, Zoledronate, Postmenopausal Osteoporosis

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.7 No.5, May 10, 2018

  ABSTRACT: Bisphosphonates are among the most frequently used antiresorptive drugs for the management of postmenopausal osteoporosis. We review here two of the commonly used bisphosphonates zoledronate and alendronate.